Cargando…
A Tool to Utilize Adverse Effect Profiles to Identify Brain-Active Medications for Repurposing
BACKGROUND: To shorten the time required to bring new treatments to clinics, recent efforts have focused on repurposing existing Food and Drug Administration (FDA)-approved drugs with established safety data for new indications. We hypothesized that adverse effect profiles might aid in prioritizing...
Autores principales: | McCoy, Thomas H., Perlis, Roy H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360243/ https://www.ncbi.nlm.nih.gov/pubmed/25673184 http://dx.doi.org/10.1093/ijnp/pyu078 |
Ejemplares similares
-
Assessment of the Performance Consistency of an Adverse Outcome Prediction Tool for Patients Hospitalized With COVID-19
por: Castro, Victor M., et al.
Publicado: (2021) -
Validation of a risk stratification tool for fall-related injury in a state-wide cohort
por: McCoy, Thomas H, et al.
Publicado: (2017) -
Assessment of Time-Series Machine Learning Methods for Forecasting Hospital Discharge Volume
por: McCoy, Thomas H., et al.
Publicado: (2018) -
Using phenome-wide association to investigate the function of a schizophrenia risk locus at SLC39A8
por: McCoy, Thomas H., et al.
Publicado: (2019) -
Differences among Research Domain Criteria score trajectories by Diagnostic and Statistical Manual categorical diagnosis during inpatient hospitalization
por: McCoy, Thomas H., et al.
Publicado: (2020)